Gamma Biosciences
Gamma Biosciences is a unique investment platform focused on supporting small to mid-size companies involved in the development and production of biopharmaceuticals. They back innovators developing tools to support the next generation of biologic medicine, working closely with management teams to identify high-impact value drivers and providing capital and expertise to support their achievement. The company leverages extensive industry experience and a powerful network to benefit its partner companies, and seeks innovative technology and business models that can shape the future of the industry.
Industries
Nr. of Employees
small (1-50)
Gamma Biosciences
Products
GMP-grade transfection reagents for viral vector manufacturing
Transfection reagent formulations and complementary kits intended to support GMP production of AAV and lentiviral vectors and to improve process productivity.
Nanofiber-based purification membranes and fit-for-purpose purification devices
High-surface-area nanofiber membrane materials and associated single-use devices designed for rapid, high-yield purification of large and fragile biologics (e.g., viral vectors).
Immunomagnetic ferrofluid reagents and cell selection workflows
Nano-magnetic ferrofluid-based reagents intended for specific cell subset selection and scalable immunomagnetic separation without reliance on column consumables.
Near-real-time process sensors and analytics for upstream/downstream control
Extensible sensor platform using tunable laser/NIR-based measurement combined with data processing to enable in-line glucose, cell density, protein concentration and aggregation monitoring.
Intensified single-use and structured bioreactor platforms for virus and vaccine production
Compact, high-density bioreactor systems and integrated manufacturing platforms designed for intensified production of viral vectors, viral vaccines and other advanced therapies.
Chromatography columns and hardware (reusable and pre-packed)
Manufacture and supply of high-performance chromatography columns, pre-packed single-use columns, and associated column hardware for biomanufacturing.
GMP-grade transfection reagents for viral vector manufacturing
Transfection reagent formulations and complementary kits intended to support GMP production of AAV and lentiviral vectors and to improve process productivity.
Nanofiber-based purification membranes and fit-for-purpose purification devices
High-surface-area nanofiber membrane materials and associated single-use devices designed for rapid, high-yield purification of large and fragile biologics (e.g., viral vectors).
Immunomagnetic ferrofluid reagents and cell selection workflows
Nano-magnetic ferrofluid-based reagents intended for specific cell subset selection and scalable immunomagnetic separation without reliance on column consumables.
Near-real-time process sensors and analytics for upstream/downstream control
Extensible sensor platform using tunable laser/NIR-based measurement combined with data processing to enable in-line glucose, cell density, protein concentration and aggregation monitoring.
Intensified single-use and structured bioreactor platforms for virus and vaccine production
Compact, high-density bioreactor systems and integrated manufacturing platforms designed for intensified production of viral vectors, viral vaccines and other advanced therapies.
Chromatography columns and hardware (reusable and pre-packed)
Manufacture and supply of high-performance chromatography columns, pre-packed single-use columns, and associated column hardware for biomanufacturing.
Services
Providing equity capital and working collaboratively with management teams to drive technical and commercial milestones.
Assistance with product development, application testing, regulatory certification planning and market launch for bioprocessing tools and consumables.
Partnerships to adapt reagents and consumables for integration with automated manufacturing platforms and to co-develop clinical-grade reagents and analytics.
Providing equity capital and working collaboratively with management teams to drive technical and commercial milestones.
Assistance with product development, application testing, regulatory certification planning and market launch for bioprocessing tools and consumables.
Partnerships to adapt reagents and consumables for integration with automated manufacturing platforms and to co-develop clinical-grade reagents and analytics.
Expertise Areas
- Advanced bioprocessing and biomanufacturing
- Bioseparations and chromatography
- Immunomagnetic cell selection
- Nucleic acid delivery and transfection
Key Technologies
- Nanofiber membrane chromatography
- Chromatography resins and adsorbents
- Immunomagnetic ferrofluids for cell selection
- Lipid-polymer nanocomplexes for nucleic acid delivery
News & Updates
Univercells Technologies Acquired by Donaldson Company
Gamma Biosciences' operating company, Univercells Technologies, was acquired by Donaldson Company, expanding its biomanufacturing solutions.
BioMagnetic Solutions Confirms ISO Certifications and GMP Facility Build in the Innovation Park at Penn State
Gamma Biosciences' portfolio company, BioMagnetic Solutions, announced the build of a GMP-grade facility and ISO certifications.
Gamma Biosciences Makes Strategic Investment in Process Analytics and Continuous Bioprocessing Company, Nirrin Technologies
Gamma invested in Nirrin Technologies to support real-time bioprocess monitoring and analysis.
Gamma Biosciences Names Terry Pizzie as CEO of Astrea Bioseparations
Terry Pizzie was appointed CEO of Astrea Bioseparations, leading the company's growth.
Gamma Biosciences to Acquire BioMagnetic Solutions, Adding Immunomagnetic Cell Separation Platform
Gamma announced the acquisition of BioMagnetic Solutions to expand its bioseparation portfolio.
Gamma Biosciences Launches Initiative Through Mirus Bio to Develop Lipid-Polymer Nanocomplexes for In Vivo mRNA Delivery
An initiative to develop advanced lipid-polymer nanocomplexes for therapeutic mRNA delivery.
Univercells Technologies Acquired by Donaldson Company
Gamma Biosciences' operating company, Univercells Technologies, was acquired by Donaldson Company, expanding its biomanufacturing solutions.
BioMagnetic Solutions Confirms ISO Certifications and GMP Facility Build in the Innovation Park at Penn State
Gamma Biosciences' portfolio company, BioMagnetic Solutions, announced the build of a GMP-grade facility and ISO certifications.
Gamma Biosciences Makes Strategic Investment in Process Analytics and Continuous Bioprocessing Company, Nirrin Technologies
Gamma invested in Nirrin Technologies to support real-time bioprocess monitoring and analysis.
Gamma Biosciences Names Terry Pizzie as CEO of Astrea Bioseparations
Terry Pizzie was appointed CEO of Astrea Bioseparations, leading the company's growth.
Gamma Biosciences to Acquire BioMagnetic Solutions, Adding Immunomagnetic Cell Separation Platform
Gamma announced the acquisition of BioMagnetic Solutions to expand its bioseparation portfolio.
Gamma Biosciences Launches Initiative Through Mirus Bio to Develop Lipid-Polymer Nanocomplexes for In Vivo mRNA Delivery
An initiative to develop advanced lipid-polymer nanocomplexes for therapeutic mRNA delivery.